Pacira BioSciences Inc (NASDAQ:PCRX) shares, rose in value, with the stock price up by 0.74% to the previous day’s close as strong demand from buyers drove the stock to $24.65.
Actively observing the price movement in the last trading, the stock closed the session at $24.47, falling within a range of $24.33 and $25.08. The value of beta (5-year monthly) was 0.708. Referring to stock’s 52-week performance, its high was $31.67, and the low was $11.16. On the whole, PCRX has fluctuated by 1.52% over the past month.
With the market capitalization of Pacira BioSciences Inc currently standing at about $1.14 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 752.94M, with a low estimate of 173.9M and a high estimate of 179.38M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 175.88M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PCRX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of PCRX currently trading nearly 0.29% and 0.10% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.23, while the 7-day volatility ratio is showing 3.66% which for the 30-day chart, stands at 5.54%. Furthermore, Pacira BioSciences Inc (PCRX)’s beta value is 0.56, and its average true range (ATR) is 1.47.
A comparison of Pacira BioSciences Inc (PCRX) with its peers suggests the former has fared considerably weaker in the market. PCRX showed an intraday change of 0.74% in last session, and over the past year, it shrunk by -8.26%%.
Data on historical trading for Pacira BioSciences Inc (NASDAQ:PCRX) indicates that the trading volumes over the past 10 days have averaged 1.26 and over the past 3 months, they’ve averaged 935.49K. According to company’s latest data on outstanding shares, there are 46.24 million shares outstanding.
Nearly 4.39% of Pacira BioSciences Inc’s shares belong to company insiders and institutional investors own 111.41% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.93 million shares as on 2025-03-31, resulting in a short ratio of 6.3. According to the data, the short interest in Pacira BioSciences Inc (PCRX) stood at 1865.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 5.86 million. The stock has risen by 30.84% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PCRX stock heading into the next quarter.
